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Abstract
Background: Pure akinesia (PA) is a distinct form of parkinsonism characterized by freezing phenomena. Little is
known about brain tumor-associated PA. We highlight the clinicoradiological changes in a patient with PA and
central nervous system (CNS) metastases of natural killer/T-cell lymphoma (NKTL).
Case presentation: A 68-year-old man with stage IVB extranodal NKTL developed a gait disturbance. Neurological
examination of his gait revealed freezing, start hesitation, short step, forward flexion posture, festination and
postural instability. Mild facial hypomimia and micrographia were observed. There was no rigidity or tremor in any
of the four extremities. Brain magnetic resonance imaging (MRI) displayed T2-hyperintense lesions in the dorsal
brainstem, cerebellum and periventricular white matter. Diffusion-weighted imaging (DWI) and the apparent
diffusion coefficient (ADC) revealed hyperintensity in these regions. Cerebrospinal fluid cytology revealed CD56-
positive cells on immunohistochemical staining. The patient’s neurological deficits did not respond to L-dopa
treatment and intrathecal administration of methotrexate (MTX). Two weeks later, he displayed confusion and
generalized convulsions. T2-hyperintense lesions spread to the basal ganglia and the infratentorial regions.
Gadolinium enhancement was observed in the cerebellum and frontal subcortex. DWI and the ADC revealed
diffusion-restricted lesions in the middle cerebellar peduncles, left internal capsules and cerebral white matter. MTX
pulse therapy and intrathecal administration of cytosine arabinoside and MTX were performed. Two months later,
his ambulatory state was normalized. Brain MRI also revealed marked alleviation of the infratentorial and
supratentorial lesions.
Conclusions: The clinicoradiological profile of our patient suggested that dorsal ponto-mesencephalic lesions
could contribute to the pathogenesis of PA. Physicians should pay more attention to striking CNS seeding of
metastatic NKTL. MTX pulse therapy had an excellent effect in improving serious symptoms and brain lesions in
our patient.
Background
Pure akinesia (PA) is a distinct form of parkinsonism
that was first reported in 1972 as freezing phenomena
only, characterized by frozen gait, micrographia and fes-
tinating speech [1]. Limb rigidity and tremor were not
observed. L-dopa treatment had no effects in PA
patients [2,3]. Many studies of neoplastic parkinsonism
have been reported [4-14]. However, little is known
about brain tumor-associated PA [4,5]. We highlight the
clinicoradiological changes in a unique patient with PA
and central nervous system (CNS) metastasis of natural
killer/T cell lymphoma (NKTL).
Case presentation
A 68-year-old man developed anorexia and exhibited
body weight loss for 2 months. Abdominal computed
tomography showed massive lesions in the adrenal
glands. Laparoscopic biopsy of the adrenal gland
demonstrated a pathological diagnosis of extranodal
NKTL (Figure 1). Clinical stage IVB was confirmed.
Two courses of DeVIC (carboplatin, etoposide, ifosfa-
mide and dexamethasone) combination chemotherapy
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ary and pancreatic lesions. Two weeks later, the patient
developed a gait disturbance and came to our neurology
department. Physical examination showed blood pres-
sure of 120/78 mm Hg and body temperature of 36.2°C.
His level of consciousness and cognitive function were
normal. Neurological examination revealed a frozen gait
with start hesitation, short step, forward flexion posture,
festination and postural instability. Kinesia paradoxale
was observed when obstacles were placed in his path.
He had mild facial hypomimia, reduced blinking, slight
slurred speech and micrographia. There was no limb
rigidity or tremor in the four extremities. The remaining
examination was normal. These neurological observa-
tions supported the clinical diagnosis of PA.
Routine laboratory studies were normal. Serum soluble
interleukin-2 receptor levels increased to 1850 U/mL
(normal range: 220-530). There were no paraneoplastic
antibodies, including antineuronal nuclear antibody types
1, 2 and 3. Serum anti-human immunodeficiency virus
antibodies were not detected. Cerebrospinal fluid (CSF)
analyses showed a mononuclear cell count of 28/mm
3
and total protein levels of 138 mg/dL. CSF cytology
revealed CD56-positive cells on immunohistochemical
staining. Infectious pathogen tests for herpes simplex,
tuberculosis, bacteria and fungus were all negative. Brain
magnetic resonance imaging (MRI) revealed T2-hyperin-
tense lesions in the dorsal brainstem, cerebellum and
periventricular white matter. Abnormal T2-intensities
were not found in the basal ganglia (Figure 2). Diffusion-
weighted imaging (DWI) and the apparent diffusion coef-
ficient (ADC) revealed a mild to moderate degree of
hyperintensity in the brainstem and cerebellum.
Neither intrathecal administration of cytosine arabino-
side (Ara-C), methotrexate (MTX) and prednisolone
(PSL), nor L-dopa treatment (levodopa 300 mg/day and
carbidopa 30 mg/day), had any effect on the patient’s
PA. Two weeks later, the patient experienced confusion
and a generalized tonic seizure. Brain MRI revealed
widespread T2-hyperintense lesions in the infratentorial
region and basal ganglia (Figure 3A-D). DWI and ADC
disclosed restricted water diffusivity in the middle cere-
bellar peduncles, brainstem, left internal capsules and
cerebral white matter (Figure 3E-L). Gadolinium
enhancement was found in the cerebellum and bilateral
frontal subcortex. There was no abnormal enhancement
in the brainstem and basal ganglia (Figure 4). The
patient’s level of consciousness deteriorated, and he
became bedridden. After intravenous MTX pulse ther-
apy (4500 mg/day) and the second intrathecal adminis-
tration of Ara-C, MTX and PSL, he recovered to normal
consciousness and became ambulatory with support. He
had no hypertensive episodes during the entire course.
Two months later, PA was ameliorated completely with-
out L-dopa treatment. CSF cytology showed no CD56-
positive cells. T2-hyperintense lesions were markedly
attenuated in the brainstem, basal ganglia and cerebral
white matter (Figure 5). DWI and ADC showed remark-
able alleviation of diffusion-restricted lesions in the mid-
dle cerebellar peduncles, brainstem and cerebral white
matter.
Discussion
We reported a patient with CNS metastases of NKTL
who had a transient course of PA and striking changes
in the brain lesions.
Figure 1 Biopsy specimen of the adrenal gland. A. Hematoxylin and eosin staining. Lymphoid cells are characterized by an intermediate size
and nuclei with irregular contours and inconspicuous nucleoli. Original magnification ×200. B. Immunohistochemical CD56 staining. Most cell
membranes are CD56 positive. Original magnification ×200.
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Page 2 of 6Figure 2 Brain T2-weighted imaging at neurological onset. A-F. Hyperintense lesions are observed in the dorsal pons, midbrain, cerebellum
and periventricular white matter. E. There were no remarkable changes in the basal ganglia.
Figure 3 Brain MRI after neurological worsening. A-D. T2-weighted image show widespread T2-hyperintense lesions in the brainstem,
cerebellum, basal ganglia and cerebral white matter. E-H. DWI shows hyperintense lesions in the middle cerebellar peduncles, midbrain, left
internal capsules and cerebral white matter. I-L. ADC shows hypointense lesions in the middle cerebellar peduncles, midbrain, left internal
capsules and cerebral white matter.
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Page 3 of 6Figure 4 Gadolinium-enhanced T1-weighted imaging. A, E. Gadolinium enhancement are found in the cerebellum (arrows) and bilateral
frontal subcortex (arrowheads). B-D, F. There is no enhancement in the brainstem and basal ganglia.
Figure 5 Brain T2-weighted imaging after neurological recovery. A-F. T2-hyperintense lesions are markedly attenuated. Hyperintense lesions
remain in the right middle cerebellar peduncle, midbrain and cerebral white matter.
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with systemic non-Hodgkin lymphoma. Most patients
have leptomeningeal or spinal epidural metastases. The
rate of CNS parenchymal metastases is only 1% [15].
NKTL is a rare type of lymphoma that usually presents
as destructive lesions within the nasal cavity. Nasal
NKTL frequently involves extranodal sites such as the
lung, skin and CNS [16]. CNS invasion or metastasis is
common in patients with nasal NKTL [17]. Most
NKTL patients have aggressive courses and unfavor-
able clinical outcomes. During PA onset, our patient
showed lesions in the brainstem and periventricular
white matter on MRI. After he exhibited confusion
and generalized convulsion, T2-hyperintense lesions
were observed in the middle cerebellar peduncles and
basal ganglia. DWI and the ADC revealed gadolinium-
enhanced and -nonenhanced diffusion-restricted
lesions in the middle cerebellar peduncles, brainstem
and cerebral white matter. These neuroradiological fea-
tures suggested the rapid relapse of brain NKTL.
Extensive MRI lesions in the cerebral white matter
have previously been described in a patient with nasal
NKTL [18]. Recent neuroradiological studies have
pointed out the inverse relationship between ADC and
the cell density of B cell lymphoma [19,20]. The clini-
coradiological worsening of our patient might have
resulted from the fulminant progression of CNS metas-
tases of NKTL and cerebral edema.
As mentioned previously, many studies of neoplastic
parkinsonism have been reported [4-14]. The following
pathogenic mechanisms underlying parkinsonism
induced by brain tumors have been proposed: 1) damage
of striatal postsynaptic cells in the basal ganglia or sub-
stantia nigra secondary to mechanical pressure or intrin-
sic involvement; 2) impairment of the pathway between
the striatum and the supplementary motor area; and 3)
compression and/or distortion of the nigrostriatal path-
way. The topographic distribution of the brain tumors is
divided into the supratentorial region and brainstem.
Compared with supratentorial tumors, the frequency of
brainstem tumor-related parkinsonism is rare. Previous
reports of neoplastic parkinsonism associated with the
midbrain lesion are summarized in Table 1. The pat-
terns of parkinsonism onset and the responses to L-
dopa were highly variable. In these reports, the patholo-
gical diagnosis was astrocytoma in three patients and B
cell lymphoma in three patients. The present patient
was diagnosed as CNS metastases of NKTL.
With respect to the pathogenesis of PA, previous
pathological studies have shown that some PA patients
had similar lesions to those of progressive supranuclear
palsy (PSP) patients [21-23]. Neuroradiological studies
have also reported matching results between PA and
PSP patients [24,25]. Only two patients with neoplastic
PA have been reported [4,5]. Suzuki et al. [4] described
a 44-year-old man with primary CNS reticulum cell sar-
coma. Pramstaller et al. [5] reported the case of a 75-
year-old man with primary CNS B cell lymphoma. This
patient did not respond to L-dopa treatment, and
autopsy demonstrated the involvement of the bilateral
globus pallidus [5]. The precise pathophysiological
mechanism of PA remains unclear. In general, PA might
contribute to both presynaptic and postsynaptic damage
in nigrostriatal dopaminergic neurons [24,25]. The mid-
brain tegmentum is the most common lesion site
between PA and PSP patients [21-23]. A dorsorostral
midbrain lesion was reported to cause PSP-like symp-
toms in a patient who had normal nigrostriatal dopami-
nergic function after resection of a pineal gland tumor
[26]. Therefore, the neuroradiological changes of our
Table 1 Previous literature of brainstem tumor-related parkinsonism
Authors [*] (years) Age/gender Histological
diagnosis
Tumor location Onset
form
L-dopa
treatment
Gherardit et al [9] (1985) 59 years/male B cell lymphoma Midbrain, thalamus Acute Excellent
response
Cicarelli et al [10] (1999) 39 years/
female
Astrocytoma Pons, midbrain Unknown No response
Yoshimura et al [11]
(2002)
63 years/
female
Astrocytoma Midbrain Chronic Excellent
response
Lin et al [12] (2010) 81 years/
male
†
B cell lymphoma Midbrain Acute No response
Hatano et al [13] (2011) 70 year/male B cell lymphoma Midbrain, hypothalamus, pineal body, thalamus,
pallidum
Acute No
administration
Wächter et al [14]
(2011)
74 years/male Astrocytoma Pons, midbrain, thalamus Chronic Moderate
response
Present patient 68 years/male NKTL Pons, midbrain, cerebellum cerebral white matter Acute No response
*Reference number.
† Complication of obstructive hydrocephalus.
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ponto-mesencephalic tegmentum could contribute to
the pathogenesis of PA.
Conclusion
We highlighted the clinicoradiological course in a
patient with transient PA and CNS metastases of NKTL.
The neuroradiological changes of the present patient
suggest that physicians should pay more attention to
fulminant progression of CNS metastases in NKTL
patients. MTX pulse therapy dramatically improved the
serious neurological deficits and brain lesions in our
patient.
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